Meet the ProBio consortium: healthcare professionals from 🇸🇪🇧🇪🇳🇴🇨🇭specialised in the treatment of men with metastatic #ProstateCancer They made the 🥈#ProBioTrial International Investigator’s Meeting a success 🙏 Presentations soon available on probiotrial.org

Don’t forget the ProBio is an investigator-initiated trial! Crazy level of commitment of everyone involved.

AR pathway inhibitors vs taxanes in #mCRPC #ProBio trial. Bram De Laere UGent joins Zach Klaassen Georgia Cancer Center to discuss the ProBio trial, a groundbreaking platform study in metastatic prostate cancer. Findings show that AR pathway inhibitors often outperform taxane-based chemo in

AR pathway inhibitors vs taxanes in #mCRPC #ProBio trial. Bram De Laere UGent joins Zach Klaassen Georgia Cancer Center to discuss the #ProBio trial, a groundbreaking platform study in metastatic prostate cancer. Findings show that AR pathway inhibitors often outperform taxane-based chemo

AR pathway inhibitors vs taxanes in #mCRPC #ProBio trial. Bram De Laere UGent joins Zach Klaassen Georgia Cancer Center to discuss the #ProBio trial, a groundbreaking platform study in metastatic prostate cancer. Findings show that AR pathway inhibitors often outperform taxane-based chemo